People | March 22, 2023
Subgroup analysis by HER2 expression from phase 1/2 trial of patients with HER3 expressing metastatic breast cancer highlighted in a second Presidential Session
The Phase 3 data presented at AAD include a comprehensive review of the THRIVE-AA2 results and further elaborate the topline data reported in August 2022
The objective of launching these products at AAHAR is to create awareness on the consumption of protein based products
This loan is in addition to earlier announced CAD 25 million loan committed by the Province of Quebec
The collaboration between both the ministries will play an important role in enhancing the skill and service sector related to Ayurveda
Proposed combination enhances Pfizer’s position as a leading company in oncology
Time to combine innovation, access and technology to deliver positive patient outcomes
IIT Kanpur pioneers ground-breaking gene therapy technology for Hereditary Eye Diseases
This new capability represents a significant shift from a microscope-based standard of care to the use of digital whole slide images
Subscribe To Our Newsletter & Stay Updated
